These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Financial conflict of interest: an unresolved ethical frontier. Kassirer JP Am J Law Med; 2001; 27(2-3):149-62. PubMed ID: 11467107 [No Abstract] [Full Text] [Related]
3. Conflicts of interest with the health industry. Dubois MY Pain Med; 2006; 7(5):463-5. PubMed ID: 17014609 [No Abstract] [Full Text] [Related]
4. The perverse consequences of a proposed global tax on research. MacDonald C; Walton N Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972 [No Abstract] [Full Text] [Related]
5. A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest. Mazzucato M; Li HL J Law Med Ethics; 2021; 49(1):39-49. PubMed ID: 33966657 [TBL] [Abstract][Full Text] [Related]
6. Balancing options for health research and development. Love J Bull World Health Organ; 2012 Nov; 90(11):796-796A. PubMed ID: 23226887 [No Abstract] [Full Text] [Related]
7. [Comments on the editorial "The health sector and the perpetual murkiness in the relations between the medical profession and the drug industry" ]. Oteo Ochoa LA Rev Calid Asist; 2009 Aug; 24(4):178-81. PubMed ID: 19647681 [No Abstract] [Full Text] [Related]
8. The unhealthy alliance between academia and corporate America. Andreopoulos S West J Med; 2001 Oct; 175(4):225-6. PubMed ID: 11577038 [No Abstract] [Full Text] [Related]
9. [Pharmaceutical industry and clinical drug research]. Huttunen MO Duodecim; 2000; 116(24):2813-5. PubMed ID: 12077886 [No Abstract] [Full Text] [Related]
10. Conflicts of interest: honours or honoraria. Sivakumaran M Lancet; 2003 Sep; 362(9387):922. PubMed ID: 13678996 [No Abstract] [Full Text] [Related]
13. Medical ethics, research and the pharmaceutical industry. Abud-Mendoza C Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694 [No Abstract] [Full Text] [Related]
14. Clinical trial results, physicians, and insider trading. Prentice RA J Leg Med; 1999 Jun; 20(2):195-222. PubMed ID: 10407617 [No Abstract] [Full Text] [Related]
15. How to do research fairly in an unjust world. Ballantyne AJ Am J Bioeth; 2010 Jun; 10(6):26-35. PubMed ID: 20526966 [TBL] [Abstract][Full Text] [Related]
16. Justice in the application of science: beyond fair benefits. London AJ Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976 [No Abstract] [Full Text] [Related]
17. Journals joust over policy on authors' interests. Wadman M Nature; 1997 Apr; 386(6626):634. PubMed ID: 9109474 [No Abstract] [Full Text] [Related]
18. Response to open peer commentaries on "How to do research fairly in an unjust world". Ballantyne AJ Am J Bioeth; 2010 Jun; 10(6):W4-6. PubMed ID: 20526959 [No Abstract] [Full Text] [Related]
19. Payments to doctors and the responsibilities of ethics committees. Diamond AL; Robinson K; Cousins J Br Med J (Clin Res Ed); 1984 Jan; 288(6413):322-3. PubMed ID: 11658728 [No Abstract] [Full Text] [Related]
20. Ethical responsibilities of physicians in their dealings with pharmaceutical companies. Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305 [No Abstract] [Full Text] [Related] [Next] [New Search]